Physician

Ali K Najar, MD

According to 2025 Medicare claims, Ali Najar, MD (NPI: 1760445688) practices pulmonary disease in the Warren-Troy-Farmington Hills, MI market, with the plurality of this provider's patient population coming from Oakland, MI. This provider's primary affiliated billing organization is OAKLAND LUNG & SLEEP SPECIALISTS PLLC (NPI: 1720671209; TIN: 85-3657766) and primary practice location at 48341-5023.

Najar's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 637 traditional Medicare patients, billed 2,774 HCPCS/CPT codes, and received $200,349 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 294 prescription claims across 79 beneficiaries totaling $219,332 in drug costs, led by Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter). DME data shows 5,971 claims. Open Payments data shows 18 records totaling $346. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $284,067 and ending at $200,349. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $143,366 and ending at $219,332. For DME billing, reported payments changed little.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,066	3,474	$284,067
2016	975	2,971	$234,546
2017	1,043	3,320	$260,826
2018	985	2,912	$223,847
2019	991	3,069	$242,575
2020	996	3,810	$297,351
2021	949	4,188	$313,377
2022	801	3,382	$235,282
2023	662	2,392	$167,657
2024	637	2,774	$200,349

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	135	535	$143,366
2016	141	604	$197,386
2017	197	851	$318,319
2018	183	749	$225,731
2019	188	784	$233,156
2020	136	507	$279,629
2021	93	390	$287,804
2022	85	308	$256,902
2023	84	293	$217,187
2024	79	294	$219,332

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	1,956	4,921	$193,299
2016	2,282	5,805	$219,834
2017	2,874	6,765	$233,594
2018	3,104	7,520	$232,313
2019	3,129	7,430	$229,087
2020	2,794	6,545	$197,496
2021	2,599	6,095	$193,564
2022	2,406	5,931	$201,194
2023	2,431	5,880	$208,898
2024	2,259	5,971	$215,308

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	131	136	$137
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	96	124	$99
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	111	308	$94
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	193	222	$70
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	100	735	$63

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	104	4,020	$83,144
Symbicort	Budesonide/Formoterol Fumarate	28	1,500	$10,698
Dulera	Mometasone/Formoterol	13	570	$6,157
Albuterol Sulfate Hfa	Albuterol Sulfate	14	533	$637
Fluticasone Propionate	Fluticasone Propionate	23	1,470	$485

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A7030	Full face mask used with positive airway pressure device, each	N	158	412	$31,265
E0601	Continuous positive airway pressure (cpap) device	Y	164	1,026	$29,645
A7031	Face mask interface, replacement for full face mask, each	N	147	375	$26,675
A4604	Tubing with integrated heating element for use with positive airway pressure device	N	294	753	$25,216
A7034	Nasal interface (mask or cannula type) used with positive airway pressure device, with or without head strap	N	190	469	$23,150

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	18	$346	GlaxoSmithKline, LLC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ali K. Najar, MD?

Tedicare shows public-source Medicare data for Ali K. Najar, MD (NPI 1760445688), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ali K. Najar, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Ali K. Najar, MD?

Ali K. Najar, MD is linked to OAKLAND LUNG & SLEEP SPECIALISTS PLLC (billing NPI 1720671209) in the available physician profile data.

Does Ali K. Najar, MD have Open Payments data?

Ali K. Najar, MD has 18 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.